Lovastatin induces relaxation and inhibits L-type Ca2+ current in the rat basilar artery

Pharmacology and Toxicology

Volumn 93, Issue 3, 2003, Pages 128-134

  Bergdahl, Andreas ^a   Persson, Erik ^a   Hellstrand, Per ^a   Swärd, Karl ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; CHOLESTEROL; FURA 2; HYPOCHOLESTEROLEMIC AGENT; ION CHANNEL; ISOPRENOID; MANGANESE; MEVALONIC ACID; MEVINOLIN; POTASSIUM; PRAVASTATIN; SEROTONIN; SIMVASTATIN;

ANIMAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CHOLESTEROL METABOLISM; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; FEMALE; IC 50; IN VITRO STUDY; LIPOPHILICITY; MUSCLE RELAXATION; NONHUMAN; PATCH CLAMP; PHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; RAT; RAT STRAIN; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE FIBER MEMBRANE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION; VOLTAGE CLAMP;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BASILAR ARTERY; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; FEMALE; LOVASTATIN; MEVALONIC ACID; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; PILOT PROJECTS; PRAVASTATIN; RATS; RATS, SPRAGUE-DAWLEY; SIMVASTATIN;

ANIMALIA;

EID: 0043237774     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2003.930304.x     Document Type: Article

References (29)

1. Alborch, E., J. B. Salom & G. Torregrosa: Calcium channels in cerebral arteries. Pharmacol. Ther. 1995, 68, 1-34.
2. Amin-Hanjani, S., N. E. Stagliano, M. Yamada, P. L. Huang, J. K. Liao & M. A. Moskowitz: Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 2001, 32, 980-986.
3. Crouse, J. R. 3rd, R. P. Byington & C. D. Furberg: HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data. Atherosclerosis 1998, 138, 11-24.
4. Dalkara, T., E. Morikawa, N. Panahian & M. A. Moskowitz: Blood flow-dependent functional recovery in a rat model of focal cerebral ischemia. Amer. J. Physiol. 1994, 267, H678-683.
5. 2+ entry into contractile vascular smooth muscle following organ culture. J. Vasc. Res. 2001, 38, 324-331.
6. Dreja, K., M. Voldstedlund, J. Vinten, J. Tranum-Jensen, P. Hellstrand & K. Swärd: Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 1267-1272.
7. Endres, M., U. Laufs, Z. Huang, T. Nakamura, P. Huang, M. A. Moskowitz & J. K. Liao: Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. 1998, 95, 8880-8885.
8. Fukata, Y., M. Amano & K. Kaibuchi: Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 2001, 22, 32-39.
9. Gelmers, H. J., K. Gorter, C. J. de Weerdt & H. J. Wiezer: A controlled trial of nimodipine in acute ischemic stroke. New Engl. J. Med. 1988, 318, 203-207.
10. Gomez, M. & P. Hellstrand: Effects of polyamines on voltage-activated calcium channels in guinea-pig intestinal smooth muscle. Pflügers Arch. 1995, 430, 501-507.
11. Gomez, M. & K. Swärd: Long-term regulation of contractility and calcium current in smooth muscle. Amer. J. Physiol. 1997, 273, C1714-1720.
12. Hamelin, B. A. & J. Turgeon: Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol. Sci. 1998, 19, 26-37.
13. Horn, J., R. J. de Haan, M. Vermeulen, P. G. Luiten & M. Limburg: Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke 2001, 32, 2433-2438.
14. Ichihara, K. & K. Satoh: Disparity between angiographic regression and clinical event rates with hydrophobic statins. Lancet 2002, 359, 2195-8.
15. Kannel, W. B., W. P. Castelli, T. Gordon & P. M. McNamara: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann. Intern. Med. 1971, 74, 1-12.
16. Liao, J. K.: Isoprenoids as mediators of the biological effects of statins. J. Clin. Invest. 2002, 110, 285-288.
17. Limbourg, F. P., Z. Huang, J. C. Plumier, T. Simoncini, M. Fujioka, J. Tuckermann, G. Schutz, M. A. Moskowitz & J. K. Liao: Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J. Clin. Invest. 2002, 110, 1729-1738.
18. Löhn, M., M. Furstenau, V. Sagach, M. Elger, W. Schulze, F. C. Luft, H. Haller & M. Gollasch: Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ. Res. 2000, 87, 1034-1039.
19. Maron, D. J., S. Fazio & M. F. Linton: Current perspectives on statins. Circulation 2000, 101, 207-213.
20. Morikawa, E., M. A. Moskowitz, Z. Huang, T. Yoshida, K. Irikura & T. Dalkara: L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 1994, 25, 429-435.
21. Multiple risk factor intervention trial: risk factor changes and mortality results. Multiple Risk factor intervention trial research group. JAMA 1982, 248, 1465-1477.
22. Neuvonen, P. J. & K. M. Jalava: Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid. Clin. Pharmacol. Ther. 1996, 60, 54-61.
23. 2+ responses in rat A10 vascular smooth muscle cells. Circ. Res. 1994, 74, 173-181.
24. 2+ channel activity and uncouples excitation from contraction in cardiac cells in culture. Proc. Natl. Acad. Sci. 1986, 83, 8007-8011.
25. Sen, L., R. A. Bialecki, E. Smith, T. W. Smith & W. S. Colucci: Cholesterol increases the L-type voltage-sensitive calcium channel current in arterial smooth muscle cells. Circ. Res. 1992, 71, 1008-1014.
26. 2+ sensitization of myosin phosphorylation and force in guinea-pig ileum. J. Physiol. 2000, 522, 33-49.
27. 2+ release and vascular reactivity. J. Cardiovasc. Pharmacol. 1999, 34, 95-101.
28. Uehata, M., T. Ishizaki, H. Satoh, T. Ono, T. Kawahara, T. Morishita, H. Tamakawa, K. Yamagami, J. Inui, M. Maekawa & S. Narumiya: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389, 990-994.
29. 2+ channels in rat islet beta-cells. Brit. J. Pharmacol. 1999, 126, 1205-1213.